Maurer M C, Peng J L, An S S, Trosset J Y, Henschen-Edman A, Scheraga H A
Baker Laboratory of Chemistry, Cornell University Biotechnology Resource Center, Ithaca, New York 14853-1301, USA.
Biochemistry. 1998 Apr 28;37(17):5888-902. doi: 10.1021/bi972538w.
Upon addition of thrombin, fibrinopeptides A and B are cleaved off from the N-termini of four chains of fibrinogen (Aalpha Bbeta gamma)2, and sites of polymerization are exposed, resulting in formation of a fibrin clot. For the fibrinogen Aalpha chain, cleavage occurs most prevalently at the Arg16-Gly17 peptide bond. About 25-30% of the human fibrinogen Aalpha chains are phosphorylated in nature at the position of Ser3, but the function for this modification is not understood. Previous NMR studies indicated that the N-terminal portion (1ADSGE5) of unphosphorylated fibrinopeptide A does not interact with the surface of bovine thrombin. Kinetic and NMR studies have now been carried out to assess whether phosphorylation at Ser3 allows the N-terminal segment (1ADSGEGDFLAEGGGVR16) to become anchored on the thrombin surface, leading to formation of a catalytically more efficient enzyme-substrate complex. Kinetic results indicate that phosphorylation leads to an approximately 65% increase in substrate specificity (kcat/Km) toward hydrolysis of fibrinogen Aalpha(1-20). 31P NMR studies reveal that the phosphorylated group does interact with thrombin, and 1H line broadening studies suggest that phosphorylation does promote binding of amino acids 1-5. Two-dimensional transferred nuclear Overhauser effect spectroscopy studies of bound fibrinopeptide A(1-16 Ser3P) indicate that phosphorylation allows new through-space interactions involving amino acid residues 1ADSGE5 to be observed. Computational docking of the peptide onto the X-ray structure of thrombin suggests that the phosphate may interact with basic residues at the rim of the heparin binding site of thrombin. As a result, the phosphate may serve as an anionic linker between the fibrinopeptide and the enzyme thrombin.
加入凝血酶后,纤维蛋白肽A和B从纤维蛋白原(AαBβγ)2的四条链的N端被切割下来,聚合位点暴露,从而形成纤维蛋白凝块。对于纤维蛋白原Aα链,切割最常发生在Arg16-Gly17肽键处。约25%-30%的人纤维蛋白原Aα链在Ser3位置天然磷酸化,但其修饰功能尚不清楚。先前的核磁共振研究表明,未磷酸化的纤维蛋白肽A的N端部分(1ADSGE5)不与牛凝血酶表面相互作用。现在已经进行了动力学和核磁共振研究,以评估Ser3处的磷酸化是否能使N端片段(1ADSGEGDFLAEGGGVR16)锚定在凝血酶表面,从而形成催化效率更高的酶-底物复合物。动力学结果表明,磷酸化导致对纤维蛋白原Aα(1-20)水解的底物特异性(kcat/Km)增加约65%。31P核磁共振研究表明,磷酸化基团确实与凝血酶相互作用,1H谱线展宽研究表明,磷酸化确实促进了氨基酸1-5的结合。结合的纤维蛋白肽A(1-16 Ser3P)的二维转移核Overhauser效应光谱研究表明,磷酸化允许观察到涉及氨基酸残基1ADSGE5的新的空间相互作用。该肽与凝血酶X射线结构的计算对接表明,磷酸可能与凝血酶肝素结合位点边缘的碱性残基相互作用。因此,磷酸可能作为纤维蛋白肽和凝血酶之间的阴离子连接体。